期刊文献+

TCT联合HPV检测诊断宫颈病变的临床价值分析 被引量:6

Analysis of the Clinical Value of TCT Combined with HPV Testing in the Diagnosis of Cervical Lesions
原文传递
导出
摘要 目的:探讨新柏氏液基细胞学技术(TCT)联合人乳头瘤病毒(human papilloma virus,HPV)检测诊断宫颈病变的临床价值。方法:选择哈尔滨医科大学附属第一医院妇科门诊收治的6752例患者,采集其宫颈脱落细胞进行TCT检测,登记患者的年龄及宫颈外观。分别随机选取TCT阳性和阴性结果的患者144例进行HPV检测及阴道镜下活检,分析和比较TCT单独及联合HPV检测诊断宫颈病变的敏感性和特异性。结果:宫颈柱状上皮细胞的外移程度及患者的年龄与宫颈TCT结果均无显著相关性。单独TCT检测诊断宫颈病变的灵敏度为87.04%,特异性为58.55%;单独HPV检测诊断宫颈病变的灵敏度为62.96%,特异性为81.62%;而联合测诊断宫颈病变的灵敏度为100%,特异度为48.29%。结论:TCT联合HPV检测可显著降低宫颈病变的漏诊率。 Objective: To study the clinical value of TCT combined with HPV testing in the diagnosis of cervical lesions. Methods:The desquamated cells of uterine tube of 6752 patients were collected in Harbin hospital and conducted the TCT test, while each patient's age and uterine tube appearance were registered. 144 cases were selected from the positive and negative results of TCT randomly and were examined by HPV and colposcopy biopsy, the sensitivity and specificity of TCT alone and combined with HPV detection in the diagnosis of cervical lesion were analyzed and compared. Results: No significant correlation was found between the moving of cells in columnar epithelium of the uterine tube and uterine tube TCT result. Moreover, no obvious correlation was found between the age and TCT result of uterine tube. The sensitivity and specificity of TCT test alone were 87.04% and 58.55% respectively, which were 62.96%and 81.62% of HPV test alone, 100% and 48.29% of TCT combined with HPV test in the diagnosis of cervical lesion. Conclusion: TCT combined with HPV detection could significantky lower the rate of missed diagnosis in the diagnosis of cervical lesions.
出处 《现代生物医学进展》 CAS 2015年第1期80-83,共4页 Progress in Modern Biomedicine
基金 中华医学会分子生物学临床应用研究专项资金(CAMB022010) 国家自然科学基金项目(30973188)
  • 相关文献

参考文献20

  • 1Trottier H, Burchell AN. Epidemiology of mucosal human papillo- mavirus infection and associated diseases[J]. Public Health Genomics, 2009, 12(5-6): 291-307.
  • 2米贤军,白宝敏,刘勇,熊小英,万波,彭学呜,钟守军,黄兆华.Thinprep液基细胞学检查在子宫颈病变诊断中的应用研究[J].中国医师杂志,2005,7(4):493-495. 被引量:11
  • 3Haverkos HW. Multifactorial etiology of cervical cancer: a hypothesis [J]. MedGenMed, 2005, 7(4): 57.
  • 4Henero R, Hildesheim A, Bratti C, et al. Population-based study of hu- man papillomavirus infection and cervical neoplasia in rural costa Ri- ca [J]..I Natl Cancer hast, 2000, 92(6): 464-474.
  • 5Dahlstrtim LA, Ylitalo N, Sundstrm K, et al. Prospective study of hu- man papillomavirus and risk of cervical adenoearcinoma [J]. hat J Cancer, 2010, 127(8): 1923-1930.
  • 6黄晓晴,李跃红,王华峰,郑娟.探讨宫颈糜烂与宫颈上皮内瘤变的关系[J].中国现代医生,2011,49(5):34-35. 被引量:9
  • 7姜桂芳.3008例已婚妇女宫颈癌筛查结果分析[J].吉林医学,2012,33(22):4812-4813. 被引量:3
  • 8Okonkwo C, Ezeanochie M, Olagbuji B. Physical after effects and clients satisfaction following colposcopy and cervical biopsy in a Nigerian population [J]. Aft Health Sci, 2013, 13(2): 402-406.
  • 9Stormo AR, Espey D, Glenn J, et al. Findings and lessons learned from a multi-partner collaboration to increase cervical cancer prevention efforts in Bolivia [J]. Rural Remote Health, 2013, 13(4): 2595.
  • 10Suh DH, Kim JW, Aziz MF, et al. Asian society of Gynecologic On- eology Workshop 2010 [J]. J Gynecol Oncol, 2010, 21(3): 137-150.

二级参考文献27

  • 1马博文,郭云泉,马丽骊.液基薄层细胞技术对宫颈上皮细胞异常筛查作用的研究[J].中华病理学杂志,2004,33(3):287-290. 被引量:84
  • 2苏涛,章桂红,程利南.液基薄层细胞学技术在宫颈病变筛查中的应用及评价[J].国外医学(妇产科学分册),2004,31(4):252-255. 被引量:112
  • 3李庭芳,陈锐.宫颈癌临床流行病学概述[J].实用医院临床杂志,2005,2(2):19-22. 被引量:62
  • 4朱静鸿,孙丽琪,刘晓杰.长春市1987~2004年宫颈癌患者死亡分析[J].中国妇幼保健,2006,21(24):3387-3388. 被引量:3
  • 5GOREY K M, HOLOWARY E J, FEHRINGER G, et al. An international comparison of cancer survival: Toronto, Ontario, and Detroit, Michigan, metropolitan areas[J]. Am J Public Health, 1997,8(7) : 1156 -1163.
  • 6HOLCOMB K, RUNOWICZ C D. Cervical cancer screening[J]. Surg Oncol Clin N Am, 2005, 14(7): 777-797.
  • 7PARKIN D M, BRAY F, FERLAY J, et al. Global cancer statistics, 2002[J]. CA Cancer J Clin, 2005, 55( 1 ) :74 - 108.
  • 8International Agency for Research on Cancer (IARC),World Health Organization.GLOBCAN2000: Cancer Incidence, Mortality and Prevalence Worldwide,Velrsionl.0.IARC Cancer Base No.5.Lyon:IARCPress, 2001.
  • 9Syraen S,Shabalova IP, Petrovichev N, et al. Human papilloma virus testing and conventional Pap smear cytology as optional screening tools of women at different risks for cervical cancer in countries of the former Soviet Union [J]. Low Genit Tract Dis,2002,6(2):97-110.
  • 10Lusk MJ, Konecony P. Celvieitis:a review[J]. Current Opinion In Infectius Dideases, 2008,21:49-55.

共引文献124

同被引文献43

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部